Skip to main content

Keyboard Shortcuts

Key Pair Function
Alt S Search Box
Alt T Top of Page
Alt H Home Page
Alt Index Button
Alt Next Button
Alt Prev Button
TLDEF Logo

TLDEF's Trans Health Project

Working for Transgender Equal Rights
Menu
  • Trans Health Insurance Tutorial
    • Choosing a Plan
    • Understanding Your Plan
    • Applying for Coverage
    • Understanding a Denial
    • Appealing a Denial
  • Resources
    • Health Insurance Medical Policies
    • Medical Organization Statements
    • State Health Insurance Laws and Guidance
    • Medicaid Regulations and Guidance
    • Gender Centers
    • Trans Health Care Providers
    • State Employee Health Plans
    • Financial Aid for Transgender Surgeries
  • Tools
    • Legal Analysis
    • Medical Necessity Literature Reviews
    • Reporting Medical Provider Discrimination
    • Training Materials for Advocates
    • Provider Medical Necessity Letter Checklists
  • About Us
    • About TLDEF's Trans Health Project
    • Privacy Policy
  • Contact Us
    • Contact TLDEF's Trans Health Project
    • Contact TLDEF
Previous Page
Prev
Home
Home
Up
Up
Next Page
Next
  •  Home
  • Resources
  • Health Insurance Medical Policies
  • Current: WellCare - Gender Reassignment Surgery

Prev Index Youth Services [79 of 81] Next

WellCare

Gender Reassignment Surgery


Policy: Gender Reassignment Surgery
Policy Number: HS-317
Last Update: 2018-03-18

This policy applies to Medicaid

This policy applies to Medicare

Breast Reconstruction:

When all of the above criteria are met for gender reassignment surgery, the following genital surgeries may be considered for transwomen (male to female): ... Mammaplasty - breast augmentation

Covered CPT Codes – when criteria are met ... 19325 Mammaplasty, augmentation; with prosthetic implant

The following services and procedures are not a covered benefit: ... Breast augmentation (unless the individual has completed a minimum of 24 months of hormone therapy during which time breast growth has been negligible, or hormone therapy is medically contraindictated or the individual is otherwise unable to take hormones);

Youth Services:

Gonadotropin-releasing hormone is considered medically necessary to suppress puberty in trans identified adolescents if they meet World Professional Association for Transgender Health (WPATH) criteria:

  • Adolescent has demonstrated a long-lasting and intense pattern of gender non-conformity or gender dysphoria (whether suppressed or expressed); AND
  • Gender dysphoria emerged or worsened with the onset of puberty; AND
  • Any co-existing psychological, medical, or social problems that could interfere with treatment (e.g., that may compromise treatment adherence) have been addressed, such that the adolescent’s situation and functioning are stable enough to start treatment; AND
  • Adolescent has given informed consent and, particularly when the adolescent has not reached the age of medical consent, the parents or other caretakers or guardians have consented to the treatment and are involved in supporting the adolescent throughout the treatment process.

Notes:

See also Gender Reassignment and Transgender Issues Clinical Practice Guideline HS-1059

Back to top

Updated on Dec 9, 2020

Donate Now Donate Now

Join Our Mailing List

Facebook Button Twitter Button Instagram Button
 Keyboard Shortcuts
 Privacy Policy
 TLDEF Website

Copyright © 2023 Transgender Legal Defense & Education Fund, Inc.  |  520 8th Avenue, Suite 2204, New York, NY 10018   Tel: 646.862.9396   Fax: 646.993.1684